NO996116L - Filmbelagt tablett for forbedret sikkerhet i ovre gastrointestinale system - Google Patents
Filmbelagt tablett for forbedret sikkerhet i ovre gastrointestinale systemInfo
- Publication number
- NO996116L NO996116L NO19996116A NO996116A NO996116L NO 996116 L NO996116 L NO 996116L NO 19996116 A NO19996116 A NO 19996116A NO 996116 A NO996116 A NO 996116A NO 996116 L NO996116 L NO 996116L
- Authority
- NO
- Norway
- Prior art keywords
- film
- coated tablet
- improved safety
- upper gastrointestinal
- gastrointestinal system
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/49—Cinchonan derivatives, e.g. quinine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4930697P | 1997-06-11 | 1997-06-11 | |
PCT/IB1998/000883 WO1998056360A2 (en) | 1997-06-11 | 1998-06-08 | Film-coated tablet for improved upper gastrointestinal tract safety |
Publications (2)
Publication Number | Publication Date |
---|---|
NO996116D0 NO996116D0 (no) | 1999-12-10 |
NO996116L true NO996116L (no) | 2000-02-11 |
Family
ID=21959131
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19996116A NO996116L (no) | 1997-06-11 | 1999-12-10 | Filmbelagt tablett for forbedret sikkerhet i ovre gastrointestinale system |
Country Status (30)
Country | Link |
---|---|
US (4) | US6165513A (sk) |
EP (1) | EP0989848B1 (sk) |
JP (3) | JP5093937B2 (sk) |
KR (1) | KR100400053B1 (sk) |
CN (1) | CN1274279A (sk) |
AR (1) | AR027158A1 (sk) |
AT (1) | ATE277606T1 (sk) |
AU (1) | AU729912B2 (sk) |
BR (1) | BR9810027A (sk) |
CA (1) | CA2293815C (sk) |
CO (1) | CO4940409A1 (sk) |
DE (1) | DE69826660T2 (sk) |
DK (1) | DK0989848T3 (sk) |
ES (1) | ES2226128T3 (sk) |
HK (1) | HK1028187A1 (sk) |
HU (1) | HUP0004625A1 (sk) |
IL (2) | IL133405A0 (sk) |
MY (1) | MY127526A (sk) |
NO (1) | NO996116L (sk) |
NZ (1) | NZ503946A (sk) |
PE (1) | PE82999A1 (sk) |
PL (1) | PL337813A1 (sk) |
PT (1) | PT989848E (sk) |
RU (1) | RU2193880C2 (sk) |
SG (1) | SG108292A1 (sk) |
SK (1) | SK284690B6 (sk) |
TR (1) | TR200000111T2 (sk) |
TW (1) | TW542725B (sk) |
WO (1) | WO1998056360A2 (sk) |
ZA (1) | ZA985010B (sk) |
Families Citing this family (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5093937B2 (ja) * | 1997-06-11 | 2012-12-12 | 味の素株式会社 | 上部胃腸管の安全性を高めるためのフィルムコーティング錠 |
AR024462A1 (es) | 1999-07-01 | 2002-10-02 | Merck & Co Inc | Tabletas farmaceuticas |
US6410520B2 (en) * | 2000-02-01 | 2002-06-25 | The Procter & Gamble Company | Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate |
US6558702B2 (en) | 2001-04-13 | 2003-05-06 | Alkermes Controlled Therapeutics, Inc. | Method of modifying the release profile of sustained release compositions |
US20060269602A1 (en) * | 2001-04-13 | 2006-11-30 | Dasch James R | Method of modifying the release profile of sustained release compositions |
US20030070584A1 (en) | 2001-05-15 | 2003-04-17 | Cynthia Gulian | Dip coating compositions containing cellulose ethers |
DE10129674A1 (de) * | 2001-06-20 | 2003-01-16 | Lohmann Gmbh & Co Kg | Hydrokolloidzusammensetzungen sowie deren Verwendung zur Herstellung redispergierbarer Beschichtungen, Filme, Folien oder Papiere |
US7183410B2 (en) * | 2001-08-02 | 2007-02-27 | Bidachem S.P.A. | Stable polymorph of flibanserin |
US20030060475A1 (en) * | 2001-08-10 | 2003-03-27 | Boehringer Ingelheim Pharma Kg | Method of using flibanserin for neuroprotection |
US8309118B2 (en) | 2001-09-28 | 2012-11-13 | Mcneil-Ppc, Inc. | Film forming compositions containing sucralose |
US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
UA78974C2 (en) | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
US20050070504A1 (en) * | 2001-12-21 | 2005-03-31 | The Procter & Gamble Co. | Risedronate compositions and their methods of use |
IL162459A0 (en) | 2001-12-24 | 2005-11-20 | Teva Pharma | Dosage form with a core table of active ingredientsheathed in a compressed annular body of powder o r granular material, and process and toolin |
JP3803672B2 (ja) * | 2002-04-11 | 2006-08-02 | テバ ファーマシューティカル インダストリーズ リミティド | 新規多形及び偽多形 |
US20040048877A1 (en) * | 2002-05-22 | 2004-03-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions containing flibanserin |
EP1396263A1 (en) * | 2002-08-09 | 2004-03-10 | Warner-Lambert Company | Film coating for tablets and caplets |
US20040043072A1 (en) * | 2002-09-04 | 2004-03-04 | Will Joanne Patricia | Alleviation of upper gastrointestinal irritation |
NZ555514A (en) * | 2002-12-20 | 2008-12-24 | Hoffmann La Roche | High dose ibandronate formulation |
TR200300510A2 (tr) * | 2003-04-18 | 2004-11-22 | Sanovel �La� Sanay� Ve T�Caret A.�. | Dağılan alendronat mikropartikül formülasyonu |
CN1893956A (zh) | 2003-07-25 | 2007-01-10 | 沃纳奇尔科特公司 | 多西环素金属络合物固体剂型 |
WO2005023270A2 (en) * | 2003-09-09 | 2005-03-17 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Compositions and methods for use of antiviral drugs in the treatment of retroviral diseases resistant to nucleoside reverse transcriptase inhibitors |
NZ545804A (en) * | 2003-09-19 | 2009-09-25 | Wisconsin Alumni Res Found | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-or-vitamin D derivatives and a bisphosphonate |
WO2005046651A1 (en) * | 2003-11-12 | 2005-05-26 | Ranbaxy Laboratories Limited | Liquid filled capsules of doxycycline |
US20050181043A1 (en) * | 2004-02-12 | 2005-08-18 | Indranil Nandi | Alendronate salt tablet compositions |
US20050239798A1 (en) * | 2004-04-22 | 2005-10-27 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for the treatment of premenstrual and other female sexual disorders |
AU2005235422B2 (en) * | 2004-04-22 | 2011-08-11 | Boehringer Ingelheim International Gmbh | New pharmaceutical compositions for the treatment of sexual disorders II |
WO2005107714A2 (en) * | 2004-05-05 | 2005-11-17 | Alkermes Controlled Therapeutics, Inc. | Method of forming microparticles that include a bisphosphonate and a polymer |
WO2006020009A1 (en) * | 2004-07-23 | 2006-02-23 | The Procter & Gamble Company | Solid oral dosage form of a bisphosphonate containing a chelating agent |
US20060025420A1 (en) * | 2004-07-30 | 2006-02-02 | Boehringer Ingelheimn International GmbH | Pharmaceutical compositions for the treatment of female sexual disorders |
CA2576812A1 (en) * | 2004-09-03 | 2006-03-09 | Boehringer Ingelheim International Gmbh | Method for the treatment of attention deficit hyperactivity disorder |
US20060062811A1 (en) * | 2004-09-21 | 2006-03-23 | Szymczak Christopher E | Medicinal cooling emulsions |
EP1802641B8 (en) * | 2004-10-08 | 2012-03-07 | The Board Of Trustees Of The University Of Illinois | Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases |
US8012949B2 (en) * | 2004-10-08 | 2011-09-06 | The Board Of Trustees Of The University Of Illinois | Bisphosphonate compounds and methods with enhanced potency for multiple targets including FPPS, GGPPS, and DPPS |
US20070271153A1 (en) * | 2004-12-23 | 2007-11-22 | Amit Goel | Method and system of aggregating listings for sale |
SG158869A1 (en) * | 2005-01-21 | 2010-02-26 | Warner Chilcott Co Llc | A tetracycline metal complex in a solid dosage form |
US20060211685A1 (en) * | 2005-03-04 | 2006-09-21 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment and/or prevention of depression |
WO2006096434A2 (en) * | 2005-03-04 | 2006-09-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders |
WO2006096439A2 (en) * | 2005-03-04 | 2006-09-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases |
CA2602184C (en) * | 2005-03-31 | 2014-07-15 | Takeda Pharmaceutical Company Limited | Tablet |
WO2006119884A2 (en) * | 2005-05-06 | 2006-11-16 | Boehringer Ingelheim International Gmbh | Method for the treatment of drug abuse with flibanserin |
WO2006125041A1 (en) * | 2005-05-19 | 2006-11-23 | Boehringer Ingelheim International Gmbh | Method for the treatment of sexual dysfunctions due to medical conditions |
CA2608363A1 (en) * | 2005-05-19 | 2006-11-23 | Boehringer Ingelheim International Gmbh | Method for the treatment of drug-induced sexual dysfunction |
US7541347B2 (en) | 2007-04-02 | 2009-06-02 | Medicis Pharmaceutical Coropration | Minocycline oral dosage forms for the treatment of acne |
US8722650B1 (en) | 2005-06-24 | 2014-05-13 | Medicis Pharmaceutical Corporation | Extended-release minocycline dosage forms |
US20080242642A1 (en) * | 2007-04-02 | 2008-10-02 | Medicis Pharmaceutical Corporation | Minocycline oral dosage forms for the treatment of acne |
US20080241235A1 (en) * | 2007-04-02 | 2008-10-02 | Medicis Pharmaceutical Corporation | Minocycline oral dosage forms for the treatment of acne |
US9192615B2 (en) | 2008-08-06 | 2015-11-24 | Medicis Pharmaceutical Corporation | Method for the treatment of acne and certain dosage forms thereof |
US8252776B2 (en) | 2007-04-02 | 2012-08-28 | Medicis Pharmaceutical Corporation | Minocycline oral dosage forms for the treatment of acne |
US7919483B2 (en) * | 2005-06-24 | 2011-04-05 | Medicis Pharmaceutical Corporation | Method for the treatment of acne |
US7544373B2 (en) * | 2007-04-02 | 2009-06-09 | Medicis Pharmaceutical Corporation | Minocycline oral dosage forms for the treatment of acne |
JP2009503020A (ja) | 2005-08-03 | 2009-01-29 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 肥満症の治療におけるフリバンセリンの使用 |
US7923449B2 (en) * | 2005-10-29 | 2011-04-12 | Boehringer Ingelheim International Gmbh | Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders |
US20070123540A1 (en) * | 2005-10-29 | 2007-05-31 | Angelo Ceci | Sexual desire enhancing medicaments comprising benzimidazolone derivatives |
US20070105869A1 (en) * | 2005-11-08 | 2007-05-10 | Stephane Pollentier | Use of flibanserin for the treatment of pre-menopausal sexual desire disorders |
US7964215B1 (en) * | 2006-01-24 | 2011-06-21 | Emet Pharmaceuticals, LLC | Delayed release dosage form |
KR20080111070A (ko) * | 2006-03-17 | 2008-12-22 | 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 | 비스포스포네이트 화합물 및 방법 |
HUE026156T2 (en) * | 2006-05-09 | 2016-06-28 | Sprout Pharmaceuticals Inc | The use of Flibanserin for the treatment of sexual desire after menopause |
DE602007004615D1 (de) * | 2006-06-30 | 2010-03-18 | Boehringer Ingelheim Pharma | Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen |
EP2043648A1 (en) * | 2006-07-14 | 2009-04-08 | Boehringer Ingelheim International GmbH | Use of flibanserin for the treatment of sexual disorders in females |
JP5793828B2 (ja) * | 2006-08-14 | 2015-10-14 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | フリバンセリンの製剤及びその製造方法 |
CL2007002214A1 (es) * | 2006-08-14 | 2008-03-07 | Boehringer Ingelheim Int | Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp |
GB0616794D0 (en) | 2006-08-24 | 2006-10-04 | Arrow Int Ltd | Solid dosage form |
JP5220746B2 (ja) * | 2006-08-25 | 2013-06-26 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 制御放出システム及びその製造方法 |
JP5676834B2 (ja) * | 2006-11-29 | 2015-02-25 | エスエス製薬株式会社 | 消化管への刺激性を減少した経口固形組成物 |
US20080241197A1 (en) * | 2007-04-02 | 2008-10-02 | Medicis Pharmaceutical Corporation | Minocycline dosage forms for the treatment of acne |
JP5441354B2 (ja) * | 2007-05-23 | 2014-03-12 | キヤノン株式会社 | インクセット、インクジェット記録方法、インクカートリッジ及びインクジェット記録装置 |
WO2009018834A1 (en) * | 2007-08-06 | 2009-02-12 | Pharmathen S.A. | Pharmaceutical composition containing bisphosphonate and method for the preparation thereof |
CL2008002693A1 (es) | 2007-09-12 | 2009-10-16 | Boehringer Ingelheim Int | Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad |
US9169279B2 (en) | 2009-07-31 | 2015-10-27 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
US20160016982A1 (en) | 2009-07-31 | 2016-01-21 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
PL2459176T3 (pl) | 2009-07-31 | 2018-02-28 | Grünenthal GmbH | Sposób krystalizacji i biodostępność |
ES2886022T3 (es) * | 2010-09-21 | 2021-12-16 | Intekrin Therapeutics Inc | Composiciones farmacéuticas sólidas antidiabéticas |
WO2012071517A2 (en) | 2010-11-24 | 2012-05-31 | Thar Pharmaceuticals, Inc. | Novel crystalline forms |
US8658631B1 (en) | 2011-05-17 | 2014-02-25 | Mallinckrodt Llc | Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia |
US8858963B1 (en) | 2011-05-17 | 2014-10-14 | Mallinckrodt Llc | Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia |
US9119793B1 (en) | 2011-06-28 | 2015-09-01 | Medicis Pharmaceutical Corporation | Gastroretentive dosage forms for doxycycline |
US9561241B1 (en) | 2011-06-28 | 2017-02-07 | Medicis Pharmaceutical Corporation | Gastroretentive dosage forms for minocycline |
WO2013015599A2 (en) * | 2011-07-28 | 2013-01-31 | Yuhan Corporation | Pharmaceutical composition for oral administration comprising bisphosphonic acid or its salt |
US10842802B2 (en) | 2013-03-15 | 2020-11-24 | Medicis Pharmaceutical Corporation | Controlled release pharmaceutical dosage forms |
EP2983657B1 (en) * | 2013-04-05 | 2020-06-03 | Numedii, Inc. | Nadolol formulations for use in the treatment of inflammatory bowel disorders |
MX2017001682A (es) * | 2014-08-04 | 2017-04-27 | Dbv Tech | Composiciones de alergenos alimentarios. |
USD787042S1 (en) * | 2015-04-28 | 2017-05-16 | Celgene Corporation | Pharmaceutical tablet |
USD787043S1 (en) * | 2015-06-23 | 2017-05-16 | Celgene Corporation | Pharmaceutical tablet |
USD809116S1 (en) | 2015-11-02 | 2018-01-30 | Pura Scents | Dispenser |
USD816506S1 (en) | 2015-11-02 | 2018-05-01 | Pura Scents, Inc. | Vial for a scent dispenser |
CA3003873C (en) | 2015-11-02 | 2020-12-22 | Brian Aaron Jones | Scent dispensation |
US10314514B2 (en) * | 2016-05-29 | 2019-06-11 | Ankon Medical Technologies (Shanghai) Co., Ltd. | System and method for using a capsule device |
US10195218B2 (en) | 2016-05-31 | 2019-02-05 | Grunenthal Gmbh | Crystallization method and bioavailability |
US11045423B2 (en) | 2016-08-08 | 2021-06-29 | Hetero Labs Limited | Anti-retroviral compositions |
ES2952878T3 (es) * | 2016-08-08 | 2023-11-06 | Hetero Labs Ltd | Una composición antirretroviral multiclase |
USD813372S1 (en) | 2017-02-22 | 2018-03-20 | Celgene Corporation | Pharmaceutical tablet |
USD835257S1 (en) | 2017-02-22 | 2018-12-04 | Celgene Corporation | Pharmaceutical tablet |
USD906513S1 (en) * | 2019-03-19 | 2020-12-29 | Novo Nordisk A/S | Pill |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4161530A (en) * | 1975-01-06 | 1979-07-17 | Ciba-Geigy Corporation | Pharmaceutical combination preparations as hypnotics |
US4252786A (en) * | 1979-11-16 | 1981-02-24 | E. R. Squibb & Sons, Inc. | Controlled release tablet |
US4302440B1 (en) * | 1980-07-31 | 1986-08-05 | Easily-swallowed, powder-free and gastric-disintegrable aspirin tablet thinly-coated with hydroxypropyl methylcellulose and aqueous spray-coating preparation thereof | |
IT207980Z2 (it) * | 1986-02-24 | 1988-03-14 | Smithkline Beckman Corp | Pastiglia farmaceutica avente corpo discoidale con contrapposte facce bombate. |
AU622254B2 (en) * | 1989-01-03 | 1992-04-02 | Sterling Drug Inc. | Controlled-release, low dose aspirin |
NZ233403A (en) * | 1989-04-28 | 1992-09-25 | Mcneil Ppc Inc | Simulated capsule-like medicament |
PH27186A (en) * | 1989-09-07 | 1993-04-16 | Ciba Geigy Ag | Double-coated granules of disodium pamidronate |
US5146730A (en) * | 1989-09-20 | 1992-09-15 | Banner Gelatin Products Corp. | Film-enrobed unitary-core medicament and the like |
RU2120798C1 (ru) * | 1991-11-22 | 1998-10-27 | Проктер энд Гэмбл Фармасьютикалз, Инк. | Твердая фармацевтическая композиция для перорального введения |
TW237386B (sk) * | 1992-04-15 | 1995-01-01 | Ciba Geigy | |
US5358941A (en) * | 1992-12-02 | 1994-10-25 | Merck & Co., Inc. | Dry mix formulation for bisphosphonic acids with lactose |
US5431920A (en) * | 1993-09-21 | 1995-07-11 | Merck Frosst, Canada, Inc. | Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents |
TW390813B (en) * | 1994-04-29 | 2000-05-21 | Merck & Co Inc | Wet granulation formulation for bisphosphonic acids |
US5534263A (en) * | 1995-02-24 | 1996-07-09 | Alza Corporation | Active agent dosage form comprising a matrix and at least two insoluble bands |
FR2738833B1 (fr) * | 1995-09-14 | 1997-12-05 | Seppic Sa | Composition filmogene pour le masquage de gout destinee a l'enrobage de formes solides ingerables telles qu'en particulier des comprimes pharmaceutiques |
DE19615812A1 (de) * | 1996-04-20 | 1997-10-23 | Boehringer Mannheim Gmbh | Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation |
JP5093937B2 (ja) * | 1997-06-11 | 2012-12-12 | 味の素株式会社 | 上部胃腸管の安全性を高めるためのフィルムコーティング錠 |
JPH11246392A (ja) * | 1998-03-03 | 1999-09-14 | Makoto Otsuka | 経口用固形製剤 |
-
1998
- 1998-06-08 JP JP50196099A patent/JP5093937B2/ja not_active Expired - Lifetime
- 1998-06-08 DK DK98921690T patent/DK0989848T3/da active
- 1998-06-08 ES ES98921690T patent/ES2226128T3/es not_active Expired - Lifetime
- 1998-06-08 IL IL13340598A patent/IL133405A0/xx unknown
- 1998-06-08 NZ NZ503946A patent/NZ503946A/xx not_active IP Right Cessation
- 1998-06-08 SG SG200200225A patent/SG108292A1/en unknown
- 1998-06-08 BR BR9810027-0A patent/BR9810027A/pt not_active Application Discontinuation
- 1998-06-08 DE DE69826660T patent/DE69826660T2/de not_active Expired - Lifetime
- 1998-06-08 CN CN98806116A patent/CN1274279A/zh active Pending
- 1998-06-08 HU HU0004625A patent/HUP0004625A1/hu not_active Application Discontinuation
- 1998-06-08 KR KR10-1999-7011668A patent/KR100400053B1/ko active IP Right Review Request
- 1998-06-08 SK SK1718-99A patent/SK284690B6/sk not_active IP Right Cessation
- 1998-06-08 AT AT98921690T patent/ATE277606T1/de active
- 1998-06-08 CA CA002293815A patent/CA2293815C/en not_active Expired - Lifetime
- 1998-06-08 AU AU74460/98A patent/AU729912B2/en not_active Expired
- 1998-06-08 WO PCT/IB1998/000883 patent/WO1998056360A2/en active IP Right Grant
- 1998-06-08 PL PL98337813A patent/PL337813A1/xx not_active Application Discontinuation
- 1998-06-08 RU RU2000100940/14A patent/RU2193880C2/ru active
- 1998-06-08 PT PT98921690T patent/PT989848E/pt unknown
- 1998-06-08 TR TR2000/00111T patent/TR200000111T2/xx unknown
- 1998-06-08 EP EP98921690A patent/EP0989848B1/en not_active Revoked
- 1998-06-10 US US09/095,322 patent/US6165513A/en not_active Expired - Lifetime
- 1998-06-10 ZA ZA985010A patent/ZA985010B/xx unknown
- 1998-06-10 PE PE1998000490A patent/PE82999A1/es not_active IP Right Cessation
- 1998-06-11 AR ARP980102774A patent/AR027158A1/es not_active Application Discontinuation
- 1998-06-11 CO CO98033551A patent/CO4940409A1/es unknown
- 1998-06-11 MY MYPI98002615A patent/MY127526A/en unknown
- 1998-07-02 TW TW087110727A patent/TW542725B/zh not_active IP Right Cessation
-
1999
- 1999-12-09 IL IL133405A patent/IL133405A/en not_active IP Right Cessation
- 1999-12-10 NO NO19996116A patent/NO996116L/no not_active Application Discontinuation
-
2000
- 2000-09-26 HK HK00106110A patent/HK1028187A1/xx not_active IP Right Cessation
- 2000-10-23 US US09/694,799 patent/US6569460B1/en not_active Expired - Lifetime
-
2003
- 2003-03-28 US US10/401,352 patent/US20030211156A1/en not_active Abandoned
-
2006
- 2006-12-01 US US11/607,241 patent/US20070071822A1/en not_active Abandoned
-
2010
- 2010-06-02 JP JP2010127107A patent/JP5229641B2/ja not_active Expired - Fee Related
-
2012
- 2012-12-04 JP JP2012265555A patent/JP2013067642A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO996116L (no) | Filmbelagt tablett for forbedret sikkerhet i ovre gastrointestinale system | |
DK0966287T3 (da) | Oxacarbazepinfilmovertrukne tabletter | |
EP1025848A4 (en) | THEOPHYLLINE TABLET WITH PROLONGED RELEASE | |
NO983265D0 (no) | Barnesikker tablettpakning | |
EE03855B1 (et) | Alfusosiinhüdrokloriidi reguleeritult vabastav tablett | |
IS5524A (is) | Forðatöflur til inntöku | |
DK0955058T3 (da) | Lactoferrintabletter | |
ZA9811504B (en) | Novel pharmaceutical. | |
IL146632A0 (en) | Pharmaceutical tablets | |
ATE300297T1 (de) | Umhüllte tablette enthaltend trimebutin maleat | |
ATE188594T1 (de) | Ionenpolymere in tablettenform | |
ZA9811505B (en) | Novel pharmaceutical. | |
AU132520S (en) | Tablet | |
AU128017S (en) | Pharmaceutical tablet | |
AU141186S (en) | Tablet | |
GB9826000D0 (en) | Tablets | |
AU129056S (en) | Pharmaceutical tablet | |
AU133610S (en) | Tablet | |
HUP9901021A3 (en) | High-content famciclovir pharmaceutical tablets | |
GB9924449D0 (en) | Rapid drug detection system | |
CA80343S (en) | Pharmaceutical tablet | |
ITBO970212A0 (it) | Macchina comprimitrice. | |
GB2326406A9 (en) | Pharmaceutical tablet card | |
CA84666S (en) | Pharmaceutical tablet | |
CA83558S (en) | Pharmaceutical tablet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application | ||
FC2A | Withdrawal, rejection or dismissal of laid open patent application |